Specker M
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:347-51.
Industry sponsors medical research in the fields of pharmaceutical products, diagnostics, medical technology, medical equipment, clinical nutrition and information systems. In pharmaceutical research, the companies of VFA invested a total of DM 4.3 billion in 1995, that means 18% of the turnover. DM 1.4 billion were spent mainly on clinical research studies. Beyond this, industry shares the costs of academic research institutes and gives support through its foundations. The decreasing number of domestic clinical studies, that German clinics complain about, is caused by organisational and administrative deficiencies, leading to major economic disadvantages. Recommendations of how to improve the situation exist and must be implemented.
企业在药品、诊断、医疗技术、医疗设备、临床营养和信息系统等领域赞助医学研究。在药物研究方面，1995年VFA成员公司总共投资了43亿德国马克，占营业额的18%。其中14亿德国马克主要用于临床研究。除此之外，企业还分担学术研究机构的费用，并通过其基金会提供支持。德国诊所所抱怨的国内临床研究数量减少，是由组织和管理缺陷造成的，这导致了重大的经济劣势。改善这种情况的建议已经存在，必须予以实施。
